Latest filing published 01 May 2018 for Eloxx Pharmaceuticals, Inc., €605k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Gilad Shabtai: trading record in brief
Gilad Shabtai appears in our data through filings on Eloxx Pharmaceuticals, Inc. shares, published by SEC (Form 4). The record holds 4 filings, for trades running from 29 March 2018 to 30 April 2018.
Purchases make up the whole of the open-market record (4 purchases, €704k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The median purchase comes to €39k. 4 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The record was last updated on 1 May 2018 with an open-market purchase (€605k) in Eloxx Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Gilad Shabtai
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 75,000 shares@ US$9.7585.9% of flowCommon StockSEC:0001209191-18-027116:0Canonical exit: 29 Jul 2018 (T+90)
- 5,700 shares@ US$9.416.2% of flowCommon StockSEC:0001209191-18-024125:0Canonical exit: 2 Jul 2018 (T+90)
- 2,600 shares@ US$9.582.9% of flowCommon StockSEC:0001209191-18-024125:1Canonical exit: 3 Jul 2018 (T+90)
- 4,500 shares@ US$9.645.0% of flowCommon StockSEC:0001209191-18-022544:0Canonical exit: 27 Jun 2018 (T+90)
4 of 4 declarations
